Prescient Therapeutics Limited (PTX.AX)
AUD 0.04
(0.0%)
AUD 0.04
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 330.48 Thousand AUD | 0.0% |
| 2023 | - AUD | 0.0% |
| 2022 | - AUD | -100.0% |
| 2021 | 165.82 Thousand AUD | 5.7% |
| 2020 | 156.88 Thousand AUD | 0.0% |
| 2019 | - AUD | -100.0% |
| 2018 | 56.04 Thousand AUD | 0.0% |
| 2017 | - AUD | 0.0% |
| 2016 | - AUD | 0.0% |
| 2015 | - AUD | 0.0% |
| 2014 | - AUD | 0.0% |
| 2013 | - AUD | -100.0% |
| 2012 | 1.1 Million AUD | 6.29% |
| 2011 | 1.03 Million AUD | 15.38% |
| 2010 | 897 Thousand AUD | -40.52% |
| 2009 | 1.5 Million AUD | 15.56% |
| 2008 | 1.3 Million AUD | 0.0% |
| 2007 | - AUD | 0.0% |
| 2006 | - AUD | 0.0% |
| 2005 | - AUD | 0.0% |
| 2004 | - AUD | 0.0% |
| 2003 | - AUD | 0.0% |
| 2002 | - AUD | 0.0% |
| 2001 | - AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| 1999 | - AUD | 0.0% |
| 1998 | - AUD | 0.0% |
| 1997 | - AUD | 0.0% |
| 1996 | - AUD | -100.0% |
| 1995 | 1.01 Million AUD | -50.95% |
| 1994 | 2.05 Million AUD | 11.9% |
| 1993 | 1.84 Million AUD | -38.32% |
| 1992 | 2.98 Million AUD | 32.58% |
| 1991 | 2.25 Million AUD | -7.45% |
| 1990 | 2.43 Million AUD | -6.5% |
| 1989 | 2.6 Million AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q4 | 330.48 Thousand AUD | 0.0% |
| 2024 Q2 | - AUD | 0.0% |
| 2024 FY | 330.48 Thousand AUD | 0.0% |
| 2023 FY | - AUD | 0.0% |
| 2023 Q2 | - AUD | 0.0% |
| 2023 Q4 | - AUD | 0.0% |
| 2022 FY | - AUD | -100.0% |
| 2022 Q2 | - AUD | 0.0% |
| 2022 Q4 | - AUD | 0.0% |
| 2021 Q4 | 165.82 Thousand AUD | 0.0% |
| 2021 FY | 165.82 Thousand AUD | 5.7% |
| 2021 Q2 | - AUD | 0.0% |
| 2020 FY | 156.88 Thousand AUD | 0.0% |
| 2020 Q2 | - AUD | 0.0% |
| 2020 Q4 | 156.88 Thousand AUD | 0.0% |
| 2019 FY | - AUD | -100.0% |
| 2019 Q4 | - AUD | 0.0% |
| 2019 Q2 | - AUD | 0.0% |
| 2018 FY | 56.04 Thousand AUD | 0.0% |
| 2018 Q4 | 56.04 Thousand AUD | 0.0% |
| 2018 Q2 | - AUD | 0.0% |
| 2017 FY | - AUD | 0.0% |
| 2017 Q4 | - AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2016 FY | - AUD | 0.0% |
| 2016 Q2 | - AUD | 0.0% |
| 2016 Q4 | - AUD | 0.0% |
| 2015 FY | - AUD | 0.0% |
| 2015 Q2 | - AUD | 0.0% |
| 2015 Q4 | - AUD | 0.0% |
| 2014 Q4 | - AUD | 0.0% |
| 2014 FY | - AUD | 0.0% |
| 2014 Q2 | - AUD | 0.0% |
| 2013 Q3 | - AUD | 0.0% |
| 2013 Q1 | - AUD | -100.0% |
| 2013 FY | - AUD | -100.0% |
| 2013 Q4 | - AUD | 0.0% |
| 2013 Q2 | - AUD | 0.0% |
| 2012 FY | 1.1 Million AUD | 6.29% |
| 2012 Q4 | 1.1 Million AUD | 0.0% |
| 2011 FY | 1.03 Million AUD | 15.38% |
| 2011 Q4 | 1.03 Million AUD | 0.0% |
| 2010 FY | 897 Thousand AUD | -40.52% |
| 2010 Q4 | 896.81 Thousand AUD | 0.0% |
| 2009 Q4 | 1.5 Million AUD | 0.0% |
| 2009 FY | 1.5 Million AUD | 15.56% |
| 2008 FY | 1.3 Million AUD | 0.0% |
| 2008 Q4 | 1.3 Million AUD | 0.0% |
| 2007 FY | - AUD | 0.0% |
| 2007 Q4 | - AUD | 0.0% |
| 2006 Q4 | - AUD | 0.0% |
| 2006 FY | - AUD | 0.0% |
| 2005 FY | - AUD | 0.0% |
| 2005 Q4 | - AUD | 0.0% |
| 2004 Q4 | - AUD | 0.0% |
| 2004 FY | - AUD | 0.0% |
| 2003 FY | - AUD | 0.0% |
| 2003 Q4 | - AUD | 0.0% |
| 2002 FY | - AUD | 0.0% |
| 2002 Q4 | - AUD | 0.0% |
| 2001 FY | - AUD | 0.0% |
| 2001 Q4 | - AUD | 0.0% |
| 2000 Q4 | - AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |
| 1999 Q4 | - AUD | 0.0% |
| 1999 FY | - AUD | 0.0% |
| 1998 FY | - AUD | 0.0% |
| 1997 FY | - AUD | 0.0% |
| 1997 Q4 | - AUD | 0.0% |
| 1996 FY | - AUD | -100.0% |
| 1995 FY | 1.01 Million AUD | -50.95% |
| 1994 FY | 2.05 Million AUD | 11.9% |
| 1993 FY | 1.84 Million AUD | -38.32% |
| 1992 FY | 2.98 Million AUD | 32.58% |
| 1991 FY | 2.25 Million AUD | -7.45% |
| 1990 FY | 2.43 Million AUD | -6.5% |
| 1989 FY | 2.6 Million AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 123.85 Thousand AUD | -166.831% |
| Anatara Lifesciences Ltd | - AUD | -Infinity% |
| Zelira Therapeutics Limited | 5.65 Million AUD | 94.154% |
| Biome Australia Limited | 1.3 Million AUD | 74.689% |
| Patrys Limited | - AUD | -Infinity% |
| Orthocell Limited | 689.69 Thousand AUD | 52.082% |
| Imugene Limited | 1.54 Million AUD | 78.636% |
| Noxopharm Limited | - AUD | -Infinity% |
| PYC Therapeutics Limited | 1.11 Million AUD | 70.301% |
| Chimeric Therapeutics Limited | - AUD | -Infinity% |
| Proteomics International Laboratories Limited | 316.39 Thousand AUD | -4.454% |
| Cynata Therapeutics Limited | - AUD | -Infinity% |
| CSL Limited | 18.24 Billion AUD | 99.998% |
| Arovella Therapeutics Limited | - AUD | -Infinity% |
| Bio-Gene Technology Limited | - AUD | -Infinity% |
| Clinuvel Pharmaceuticals Limited | 879.78 Thousand AUD | 62.436% |
| Starpharma Holdings Limited | 3.52 Million AUD | 90.632% |
| Nanollose Limited | 42.53 Thousand AUD | -677.066% |
| Memphasys Limited | 4.41 Million AUD | 92.511% |
| Invex Therapeutics Ltd | - AUD | -Infinity% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Amplia Therapeutics Limited | 1.56 Million AUD | 78.838% |
| Botanix Pharmaceuticals Limited | - AUD | -Infinity% |
| Island Pharmaceuticals Limited | 421.96 Thousand AUD | 21.68% |
| Race Oncology Limited | - AUD | -Infinity% |
| Nyrada Inc. | - AUD | -Infinity% |
| Telix Pharmaceuticals Limited | 17.44 Million AUD | 98.106% |
| Dimerix Limited | 149.68 Thousand AUD | -120.791% |
| PharmAust Limited | - AUD | -Infinity% |
| Immutep Limited | 1.22 Million AUD | 73.093% |
| Clarity Pharmaceuticals Ltd | - AUD | -Infinity% |
| Alterity Therapeutics Limited | 159.04 Thousand AUD | -107.794% |
| BTC Health Limited | - AUD | -Infinity% |
| Acrux Limited | 1.48 Million AUD | 77.775% |
| Neuren Pharmaceuticals Limited | - AUD | -Infinity% |
| Biotron Limited | 7130.00 AUD | -4535.147% |
| Tissue Repair Ltd | - AUD | -Infinity% |
| AdAlta Limited | 2.49 Million AUD | 86.752% |
| Radiopharm Theranostics Limited | - AUD | -Infinity% |
| Hexima Limited | - AUD | -Infinity% |
| AnteoTech Limited | 23.59 Thousand AUD | -1300.839% |
| Paradigm Biopharmaceuticals Limited | 239.33 Thousand AUD | -38.088% |
| Recce Pharmaceuticals Ltd | 811.19 Thousand AUD | 59.259% |
| Avecho Biotechnology Limited | 175.15 Thousand AUD | -88.686% |
| Actinogen Medical Limited | 319.06 Thousand AUD | -3.578% |
| Immuron Limited | 173.49 Thousand AUD | -90.485% |
| Argenica Therapeutics Limited | - AUD | -Infinity% |